Ethical and equity issues in lung transplantation and lung volume reduction surgery

Chronic Respiratory Disease

Volumn 3, Issue 1, 2006, Pages 53-58

  Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Equity; Ethics; Lung transplantation; Lung volume reduction surgery

Indexed keywords

ETHICS; HEALTH PROGRAM; HOSPITAL ADMISSION; LUNG DISEASE; LUNG RESECTION; LUNG TRANSPLANTATION; LUNG VOLUME; MEDICAL ETHICS; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; RECIPIENT; RESOURCE ALLOCATION; REVIEW; TREATMENT PLANNING;

CONFLICT OF INTEREST; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFORMED CONSENT; LUNG TRANSPLANTATION; PATIENT SELECTION; PNEUMONECTOMY; RESOURCE ALLOCATION; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 32444434451     PISSN: 14799723     EISSN: None     Source Type: Journal    
DOI: 10.1191/1479972306cd091ra     Document Type: Review

References (37)

1. Lawrence EC. Ethical issues in lung transplantation. Am J Med Sci 1998; 315: 142-45.
2. Mackenzie KM. Philosophical and ethical issues in human organ transplantation. Br J Nurs 2001; 10: 433-37.
3. Finder SG, Fox MD, Frist WH, Zaner RM. The ethicist's role on the transplant team: a study of heart, lung, and liver transplantation programs in the United States. Clin Transplant 1993; 7: 559-64.
4. Munro PE, Bailey MJ, Smith JA, Snell GI. Lung volume reduction surgery in Australia and New Zealand. Six years on: registry report. Chest 2003; 124: 1443-50.
5. Meyers BF, Patterson GA. Lung transplantation versus lung volume reduction as surgical therapy for emphysema. World J Surg 2001; 25: 238-43.
6. Evans RW. Public and private insurer designation of transplantation programs. Transplantation 1992; 53: 1041-46.
7. Evans RW. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. In Terashi PI, Cecka JM eds Clinical Transplants. Los Angeles, CA: UCLA, 1993: 359-91.
8. Antioch KM, Walsh MK. Risk-adjusted capitation funding models for chronic disease in Australia: alternatives to casemix funding. Eur J Health Econ 2002; 3: 83-93.
9. Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J 2003; 22: 845-52.
10. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998; 66: 951-56.
11. Daly RC, McGregor CG. Surgical issues in lung transplantation: options, donor selection, graft preservation, and airway healing. Mayo Clin Proc 1997; 72: 79-84.
12. Hartwig MG, Davis RD. Surgical considerations in lung transplantation: transplant operation and early postoperative management. Respir Care Clin N Am 2004; 10: 473-504.
13. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004; 24: 674-85.
14. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report - 2004. J Heart Lung Transplant 2004; 23: 804-15.
15. Grady D. Healthy give organs to dying, raising issues of risk and ethics. NY Times (Print) 20011; A1, A16.
16. Kolata G. Lungs from parents fail to save girl, 9, and doctors assess ethics. NY Times (Print) 1991; A11.
17. Cohen S. Tangled lifeline. Washington Post 1996; 10-15, 26-32.
18. Miranda B, Matesanz R. International issues in transplantation. Setting the scene and flagging the most urgent and controversial issues. Ann N Y Acad Sci 1998; 862: 129-43.
19. Aigner C, Seebacher G, Klepetko W. Lung transplantation. Donor selection. Chest Surg Clin N Am 2003; 13: 429-42.
20. Simonds AK. Ethics and decision making in end stage lung disease. Thorax 2003; 58: 272-77.
21. Egan TM, Bennett LE, Garrity ER et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 2001; 20: 242.
22. Pierson RN, Milstone AP, Loyd JE, Lewis BH, Pinson CW, Ely EW. Lung allocation in the United States, 1995-1997: an analysis of equity and utility. J Heart Lung Transplant 2000; 19: 846-51.
23. Valapour M. Ethics of organ distribution in lung transplantation. Minn Med 2004; 87: 36-37.
24. Manzetti JD, Ankeny R, Miller D. Psychosocial and ethical issues in surgical approaches to end-stage lung disease. Clin Chest Med 1997; 18: 383-90.
25. Egan TM. Ethical issues in thoracic organ distribution for transplant. Am J Transplant 2003; 3: 366-72.
26. Cabrol C. Ethical and social problems posed by organ transplantation. Bull Acad Natl Med 1992; 176: 1097-107; discussion 1107-10.
27. Cabrol C. Ethical and social problems posed by organ transplantation. Ann Gastroenterol Hepatol (Paris) 1993; 29: 93-97.
28. Robin ED. The kingdom of the near-dead. The shortened unnatural life history of primary pulmonary hypertension. Chest 1987; 92: 330-34.
29. Berger RL, Celli BR, Meneghetti AL et al. Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac Surg 2001; 72: 649-57.
30. Ault A. US government to pay for lung volume reduction surgery. Lancet 2003; 362: 71
31. Ramsey SD. Cost effectiveness of lung volume reduction surgery. Chest Surg Clin N Am 2003; 13: 727-38, vii-viii.
32. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003; 348: 2092-102.
33. Miller JD, Coughlin MD, Edey L, Miller P, Sivji Y. Equipoise and the ethics of the Canadian Lung Volume Reduction Surgery Trial study: should there be a randomized, controlled trial to evaluate lung volume reduction surgery? Can Respir J 2000; 7: 329-32.
34. Fishman A, Martinez F, Naunheim K et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-73.
35. Martinez FJ, Flaherty KR, Iannettoni MD. Patient selection for lung volume reduction surgery. Chest Surg Clin N Am 2003; 13: 669-85.
36. McKenna RJ Jr. Complications after lung volume reduction surgery. Chest Surg Clin N Am 2003; 13: 701-708.
37. Tonelli MR, Benditt JO, Albert RK. Clinical experimentation. Lessons from lung volume reduction surgery. Chest 1996; 110: 230-38.